WHO Urges Accelerated Efforts to Eradicate TB in South-East Asia
The World Health Organization's South-East Asia Region has thrown down the gauntlet in the fight against tuberculosis, undertaking a robust commitment to accelerate its eradication by 2030. The Gandhinagar Declaration, adopted by member states, signals a renewed vigour in addressing the epidemic that disproportionately affects the region.
Despite efforts leading to progress over recent years, the region remains at the epicentre of the global TB crisis, accounting for nearly half of the world's cases and deaths. In 2024 alone, an estimated 3.68 million new TB cases were reported, with the disease claiming 433,000 lives. The need for decisive action is palpable.
Closing the Gap
The declaration comes with a call for enhanced political commitment and multi-sectoral efforts at the highest levels. Dr Boehme of WHO emphasised that the tools to end TB are already available, but the time to utilise them effectively is now. She noted the importance of leadership, innovation, and collaboration in driving the initiative forward.
Central to this strategy is addressing the socio-economic factors that exacerbate the disease's spread. Poverty, inadequate healthcare infrastructure, and limited access to medical services are formidable barriers in many South-East Asian countries. Tackling these issues is crucial for closing the gap between need and action.
Global Implications
Success in South-East Asia could set a precedent for tackling TB globally. The region's commitment serves as a clarion call for international cooperation and resource mobilisation. WHO has stressed that achieving the goals of the Gandhinagar Declaration requires collective action, not just from individual countries, but from the global community.
The stakes are high, but the potential rewards are significant. Ending TB in South-East Asia could herald a new era in public health success, reflecting the region's capacity for resilience and innovation against one of the world's most persistent health challenges.